Improved intravaginal controlled-release prostaglandin E2 insert for cervical ripening at term. The Prostaglandin E2...

Area of Science:

• Obstetrics and Gynecology
• Reproductive Medicine
• Pharmacology

Background:

• Cervical ripening is crucial for initiating labor at term.
• Effective methods for cervical ripening are essential for optimizing delivery outcomes.
• Prostaglandin E2 (PGE2) is a key mediator in reproductive processes.

Purpose of the Study:

• To evaluate the efficacy of a controlled-release vaginal insert containing prostaglandin E2 (PGE2) for cervical ripening in term pregnancies.
• To assess the safety and effectiveness of PGE2 vaginal inserts in a multicenter, double-blind, randomized, placebo-controlled trial.

Main Methods:

• A multicenter, double-blind, randomized, placebo-controlled study was conducted with 206 term patients.
• Patients received either a PGE2-releasing vaginal insert or a placebo insert.
• Outcomes were assessed by changes in Bishop score, time to delivery, and cesarean delivery rates.

Main Results:

• The PGE2 group showed a significantly greater change in Bishop score (62% vs. 40%; P = 0.002).
• Successful outcomes were achieved in 65% of the PGE2 group versus 44% of the placebo group (P = 0.001).
• No significant difference in cesarean delivery rates was observed; uterine hyperstimulation occurred in 4.9% of the PGE2 group.

Conclusions:

• Controlled-release prostaglandin E2 (PGE2) vaginal inserts are effective for promoting cervical ripening at term.
• The PGE2 insert offers a viable option for labor induction, improving cervical readiness.
• The safety profile, including rates of hyperstimulation, was acceptable in this study population.